Did not become law. It stopped in the Senate's Commerce Committee on February 1, 2018. The 2018–2019 session has ended.
2018–2019 Session
Senate Bill 1294
Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor from Oct 24, 2019
Chief co-sponsor from Jan 25
Its course
February 1 to February 1, 2018, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the SenateFeb 1 to Feb 1 · stopped0 days
CommerceFeb 1 to Feb 1 · stopped0 days
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.